Evidence map›Paper›PMID 39611488›Full record

ArticleInternational journal of oncology2025

Anti‑angiogenic effect of

Heabin Kim, Seung-Hyun Jung, Seonmi Jo, Jong Won Han, Moongeun Yoon, Jei Ha Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Heabin Kim *Department of Bio‑material Research, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.
Seung-Hyun Jung *Department of Bio‑material Research, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.
Seonmi JoDepartment of Biological Application & Technology, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.
Jong Won HanDepartment of Ecology & Conservation, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.
Moongeun YoonDepartment of Bio‑material Research, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.
Jei Ha LeeDepartment of Bio‑material Research, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing novel anti‑angiogenic agents with minimal toxicity is notably challenging for cancer therapeutics. The discovery and development of peptides, whether derived from natural sources or synthesized, has potential for developing anti‑angiogenic agents characterized by their ability to penetrate cancer cells, high specificity and low toxicity. The present study identified a

Indexed as

Angiogenesis InhibitorsAquaporin 3Carcinoma, Non-Small-Cell LungHuman Umbilical Vein Endothelial CellsLung NeoplasmsZebrafishAnimalsCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansNeovascularization, PathologicPeptidesAngiogenesis InhibitorsAQP3 protein, humanAquaporin 3Peptidesangiogenesisanticancer peptidenon‑small cell lung cancerzebrafish

Identifiers

PMID39611488
PMCPMC11637497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.